Cetera Advisors’s Quest Diagnostics DGX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $375K | Buy |
2,818
+1,195
| +74% | +$159K | ﹤0.01% | 1795 |
|
|
2023
Q4 | $224K | Sell |
1,623
-701
| -30% | -$96.7K | ﹤0.01% | 1584 |
|
|
2023
Q3 | $283K | Buy |
2,324
+346
| +17% | +$42.2K | ﹤0.01% | 1350 |
|
|
2023
Q2 | $278K | Sell |
1,978
-752
| -28% | -$106K | ﹤0.01% | 1347 |
|
|
2023
Q1 | $386K | Sell |
2,730
-198
| -7% | -$28K | 0.01% | 1149 |
|
|
2022
Q4 | $458K | Buy |
2,928
+1,190
| +68% | +$186K | 0.01% | 1024 |
|
|
2022
Q3 | $213K | Sell |
1,738
-89
| -5% | -$10.9K | 0.01% | 1107 |
|
|
2022
Q2 | $243K | Buy |
1,827
+7
| +0.4% | +$931 | 0.01% | 1135 |
|
|
2022
Q1 | $249K | Sell |
1,820
-80
| -4% | -$10.9K | 0.01% | 1198 |
|
|
2021
Q4 | $329K | Hold |
1,900
| – | – | 0.01% | 1082 |
|
|
2021
Q3 | $276K | Sell |
1,900
-65
| -3% | -$9.44K | 0.01% | 1151 |
|
|
2021
Q2 | $259K | Sell |
1,965
-191
| -9% | -$25.2K | 0.01% | 1116 |
|
|
2021
Q1 | $277K | Buy |
2,156
+130
| +6% | +$16.7K | 0.01% | 993 |
|
|
2020
Q4 | $241K | Buy |
2,026
+40
| +2% | +$4.76K | 0.01% | 907 |
|
|
2020
Q3 | $227K | Sell |
1,986
-112
| -5% | -$12.8K | 0.01% | 837 |
|
|
2020
Q2 | $239K | Buy |
+2,098
| New | +$239K | 0.01% | 779 |
|
|
2020
Q1 | – | Sell |
-1,963
| Closed | -$210K | – | 834 |
|
|
2019
Q4 | $210K | Buy |
+1,963
| New | +$210K | 0.01% | 850 |
|
|
2019
Q3 | – | Sell |
-2,116
| Closed | -$217K | – | 908 |
|
|
2019
Q2 | $217K | Buy |
+2,116
| New | +$217K | 0.01% | 829 |
|
|
2018
Q4 | – | Sell |
-3,220
| Closed | -$349K | – | 867 |
|
|
2018
Q3 | $349K | Buy |
+3,220
| New | +$349K | 0.02% | 679 |
|
|
2016
Q4 | – | Sell |
-3,289
| Closed | -$278K | – | 744 |
|
|
2016
Q3 | $278K | Buy |
+3,289
| New | +$278K | 0.02% | 576 |
|